6-(1-(4-methylpiperazin-1-yl)ethyl)quinolin-8-yl ethyl(methyl)carbamate

ID: ALA4446271

Chembl Id: CHEMBL4446271

PubChem CID: 155518792

Max Phase: Preclinical

Molecular Formula: C20H28N4O2

Molecular Weight: 356.47

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CCN(C)C(=O)Oc1cc(C(C)N2CCN(C)CC2)cc2cccnc12

Standard InChI:  InChI=1S/C20H28N4O2/c1-5-23(4)20(25)26-18-14-17(13-16-7-6-8-21-19(16)18)15(2)24-11-9-22(3)10-12-24/h6-8,13-15H,5,9-12H2,1-4H3

Standard InChI Key:  UOQFVMNZVYSSHQ-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA4446271

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 356.47

Molecular Weight (Monoisotopic): 356.2212

AlogP: 2.99

#Rotatable Bonds: 4

Polar Surface Area: 48.91

Molecular Species: NEUTRAL

HBA: 5

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 7.83

CX LogP: 2.41

CX LogD: 1.84

Aromatic Rings: 2

Heavy Atoms: 26

QED Weighted: 0.84

Np Likeness Score: -1.11

References

1. Huang W, Liang M, Li Q, Zheng X, Zhang C, Wang Q, Tang L, Zhang Z, Wang B, Shen Z..  (2019)  Development of the "hidden" multifunctional agents for Alzheimer's disease.,  177  [PMID:31158742] [10.1016/j.ejmech.2019.05.051]

Source

Source(1):

• Scientific Literature